Health & Biotech is a company specializing in placenta-umbilical cord derived stem cells storage, research and application. With a foundation date of 2007, the company has a multi-faceted approach to its operations, encompassing stem-cell storage (via placenta and umbilical cord), provision of stem cell therapies within the Chinese healthcare market, as well as research and development of new stem cell-based medicine and large-scale manufacturing and storage processes. Additionally, the company has ventured into the field of stem cell-based cosmetics applications. Notably, Health & Biotech has established 4 stem cells production bases across China, including locations in Beijing, Guangdong, Henan, and Shandong. The industries under which the company operates include Biotechnology and Life Sciences. Overall, Health & Biotech's focus on stem cell research and application presents an intriguing opportunity for investors, particularly in the burgeoning field of biotechnology. The company's broad scope of operations, from storage to therapy provision, along with its regional production bases across China, indicates a strong infrastructure and potential for growth. As a venture capital firm seeking investment opportunities in the health and biotech sectors, Health & Biotech presents a compelling proposition with its established presence in the Chinese market and its multifaceted approach to stem cell-based solutions.
There is no investment information
No recent news or press coverage available for Health & Biotech.
We care about your data, and we'd love to use cookies make your experience better.
